Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Titre (en) » - entrée « against »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
after < against < age  Facettes :

List of bibliographic references indexed by against

Number of relevant bibliographic references: 43.
[0-20] [0 - 20][0 - 43][20-40]
Ident.Authors (with country if any)Title
000049 (2020) Yeimer Ortiz-Martínez [Colombie]Tocilizumab: A new opportunity in the possible therapeutic arsenal against COVID-19.
000199 (2020) Tarek Mohamed Abd El-Aziz [États-Unis, Égypte] ; James D. Stockand [États-Unis]Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status
000223 (2020) Chih-Chia Lu [République populaire de Chine] ; Mei-Yu Chen [République populaire de Chine] ; Yuh-Lih ChangPotential therapeutic agents against COVID-19: What we know so far
000321 (2020) Biswaranjan Paital [Inde] ; Kabita Das [Inde] ; Sarat Kumar Parida [Inde]Inter nation social lockdown versus medical care against COVID-19, a mild environmental insight with special reference to India
000373 (2020) Hongzhuan Xuan [République populaire de Chine] ; Aiqun Ou ; Shengyu Hao ; Jiajun Shi ; Xiaolu Jin [République populaire de Chine]Galangin Protects against Symptoms of Dextran Sodium Sulfate-Induced Acute Colitis by Activating Autophagy and Modulating the Gut Microbiota
000383 (2020) Hai-Jian Tu [République populaire de Chine] ; Cheng-Fei Zhao [République populaire de Chine] ; Zhi-Wei Chen [République populaire de Chine] ; Wei Lin [République populaire de Chine] ; Yu-Cai Jiang [République populaire de Chine]Fibroblast Growth Factor (FGF) Signaling Protects Against Acute Pancreatitis-Induced Damage by Modulating Inflammatory Responses
000451 (2020) Yue Zhang ; Qianhao Xu ; Zhuoyan Sun ; Lei ZhouCurrent targeted therapeutics against COVID-19: based on first-line experience in china
000524 (2020) Dwight L. Mckee [États-Unis] ; Ariane Sternberg [Allemagne] ; Ulrike Stange [Allemagne] ; Stefan Laufer [Allemagne] ; Cord Naujokat [Allemagne]Candidate drugs against SARS-CoV-2 and COVID-19
000573 (2020) Izabela Szczygielska ; El Bieta Hernik ; Agnieszka Gazda ; Beata Kołodziejczyk ; Piotr GietkaAssessment of anti-HBs antibody concentration in children with juvenile idiopathic arthritis treated with biological drugs, vaccinated against viral type B hepatitis in infancy
000926 (2019) Caitlyn L. Holmes [États-Unis] ; Chloe G. Peyton [États-Unis] ; Amy M. Bier [États-Unis] ; Tobias Z. Donlon [États-Unis] ; Fauzia Osman [États-Unis] ; Christie M. Bartels [États-Unis] ; Miriam A. Shelef [États-Unis]Reduced IgG titers against pertussis in rheumatoid arthritis: Evidence for a citrulline-biased immune response and medication effects
000C16 (2019) Sakiko Tabata [Japon] ; Tomoaki Higuchi [Japon] ; Seishiro Tatsukawa [Japon] ; Kazuyuki Narimatsu [Japon] ; Hiroaki Takeo [Japon] ; Susumu Matsukuma [Japon] ; Toshimitsu Ito [Japon]Idiopathic Multicentric Castleman Disease with Autoimmune Hemolytic Anemia and Production of Anti-drug Antibody against Tocilizumab
000F45 (2019) Monika Christ ; Torsten Müller ; Corinna Bien ; Thomas Hagen ; Markus Naumann ; Antonios BayasAutoimmune encephalitis associated with antibodies against the metabotropic glutamate receptor type 1: case report and review of the literature
001118 (2018) Tao-Cheng Wu [Taïwan] ; Chih-Yao Chiang [Taïwan] ; Jenq-Shyong Chan [Taïwan] ; Chiu-Yang Lee [Taïwan] ; Hsin-Bang Leu [Taïwan] ; Po-Hsun Huang [Taïwan] ; Jia-Shiong Chen [Taïwan] ; Shing-Jong Lin [Taïwan] ; Jaw-Wen Chen [Taïwan]Tocilizumab, a Humanized Monoclonal Antibody Against the Interleukin-6 Receptor, Inhibits High Glucose-Induced Vascular Smooth Muscle Cell Migration Through Mitogen-Activated Protein Kinase Signaling Pathways.
001372 (2018) Susann Albert [Allemagne] ; Claudia Arndt [Allemagne] ; Stefanie Koristka [Allemagne] ; Nicole Berndt [Allemagne] ; Ralf Bergmann [Allemagne] ; Anja Feldmann [Allemagne] ; Marc Schmitz [Allemagne] ; Jens Pietzsch [Allemagne] ; Jörg Steinbach [Allemagne] ; Michael Bachmann [Allemagne]From mono- to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells in vitro and in vivo
001624 (2017) Stefan Rose-John [Allemagne] ; Kevin Winthrop [États-Unis] ; Leonard Calabrese [États-Unis]The role of IL-6 in host defence against infections: immunobiology and clinical implications.
001684 (2017) Muznay N. Khawaja [États-Unis] ; Martin J. Bergman [États-Unis] ; Jeffrey Yourish [États-Unis] ; Jinglan Pei [États-Unis] ; William Reiss [États-Unis] ; Edward Keystone [Canada]Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab.
001737 (2017) Taghreed Hirz [France] ; Eva-Laure Matera [France] ; Kamel Chettab [France] ; Lars Petter Jordheim [France] ; Doriane Mathé [France] ; Anne Evesque [France] ; Justine Esmenjaud [France] ; Gilles Salles [France] ; Charles Dumontet [France]Neutrophils protect lymphoma cells against cytotoxic and targeted therapies through CD11b/ICAM-1 binding
001B42 (2016) Songsong Li ; Zhenzhou Wu ; Ling Li ; Xuehua LiuInterleukin-6 (IL-6) Receptor Antagonist Protects Against Rheumatoid Arthritis.
001B50 (2016) Lucille Desallais [France] ; Caroline Bouchez [France] ; Hadley Mouhsine [France] ; Gabriel Moreau [France] ; Rojo Ratsimandresy [France] ; Matthieu Montes [France] ; Hervé Do [France] ; Françoise Quintin-Colonna [France] ; Jean-François Zagury [France]Immunization against an IL-6 peptide induces anti-IL-6 antibodies and modulates the Delayed-Type Hypersensitivity reaction in cynomolgus monkeys
001E55 (2015) Keisuke Izumi [Japon] ; Harumi Kuda [Japon] ; Mari Ushikubo [Japon] ; Masataka Kuwana [Japon] ; Tsutomu Takeuchi [Japon] ; Hisaji Oshima [Japon]Tocilizumab is effective against polymyalgia rheumatica: experience in 13 intractable cases.
001E85 (2015) M. Ollé [Espagne]The European League Against Rheumatism (EULAR) - 16th Annual European Congress (June 10-13, 2015 - Rome, Italy).

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "against" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "against" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    against
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021